The Oncology Institute Inc. (TOI)
NASDAQ (CM) NASDAQ (CM) Primary Summary
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%
The average of price targets set by Wall Street analysts indicates a potential upside of 38.1% in The Oncology Institute (TOI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Oncology Institute Q1 Earnings Call Highlights
Oncology Institute NASDAQ: TOI reported a strong start to 2026, with first-quarter revenue rising 41% year over year as the company expanded value-based care arrangements and posted record specialty pharmacy performance.
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
The Oncology Institute, Inc. (TOI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago.
The Oncology Institute Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JC Joseph Castro Nuveen LLC | 95,264 | $214,255.35 | $488,704.32 | $274,448.97 | 128.09% |
| BA Bobby Adusumilli SJS Investment Consulting Inc. | 459 | $1,601.91 | $2,354.67 | $752.76 | 46.99% |
| DH Dinan Hu R Squared Ltd | 16,353 | $55,820.46 | $83,890.89 | $28,070.43 | 50.29% |
 Alexandra Stickelman Root Financial Partners, LLC | 51 | $157 | $261.63 | $104.63 | 66.64% |
 Rajiv Shah KINGSWOOD WEALTH ADVISORS, LLC | 98,700 | $253,204 | $506,331 | $253,127 | 99.97% |
The Oncology Institute Inc. (TOI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has The Oncology Institute Inc. ever had a stock split?
The Oncology Institute Inc. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Daniel Virnich CEO | NASDAQ (CM) Exchange | 68236X100 CUSIP |
| US Country | 825 Employees | - Last Dividend | - Last Split | 15 Nov 2021 IPO Date |
Overview
The Oncology Institute, Inc. is an American oncology company specializing in a wide range of oncology services. Founded in 2007 and headquartered in Cerritos, California, the institute is dedicated to providing comprehensive care for adult and senior cancer patients. With 67 clinic locations across the United States, it offers a broad spectrum of integrated services aimed at the management and treatment of cancer. The company's approach to cancer care includes a combination of medical oncology services, innovative therapies, and patient support programs designed to address the individual needs of each patient.
Products and Services
- Physician Services: Consists of consultations, diagnosis, and treatment plans developed by experienced oncologists. The Oncology Institute prides itself on employing skilled physicians who are dedicated to providing personalized and comprehensive care to each patient.
- In-house Infusion and Dispensary: Offers convenient on-site access to chemotherapy and other medication infusions. This service allows patients to receive their treatment in a comfortable and controlled environment, supervised by the institute's medical professionals.
- Clinical Trial Services: Participates in and manages clinical trials aimed at exploring new cancer treatments and therapies. By providing access to cutting-edge clinical trials, the Oncology Institute plays a crucial role in advancing cancer research and offering hope for innovative treatment options to its patients.
- Radiation: Includes advanced radiation therapy options as part of a comprehensive cancer treatment plan. Radiation therapy is used to target and destroy cancer cells, and is often combined with other treatments for optimal outcomes.
- Outpatient Stem Cell Transplants and Transfusions Programs: Provides advanced treatments like stem cell transplants and blood transfusions on an outpatient basis, reducing the need for hospital stays and allowing patients to recover in the comfort of their own homes.
- Patient Support: Focuses on the well-being of patients beyond clinical treatment, offering services that include palliative care programs designed to help manage symptoms and improve quality of life. The company recognizes the importance of holistic care and strives to support patients and their families throughout the cancer journey.
